Vroman Ken's Form 4 filing
CME Group Inc.CME · filed Mar 12, 2026
- Accession no.
- 0001628280-26-017392
- Filed
- Mar 12, 2026
- Trade date
- Mar 12, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.59M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vroman KenCIK 0001429863 | Officer (Chief Transformation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock Class A | SSaleDisposed | −5,160 | $309.00F1 | −$1,594,440 | 14,910 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On March 12, 2026, Mr. Vroman sold an aggregate of 5160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $308.969 to $309.11. The Company maintains a record of the transaction and copies will be provided upon request.
Referenced by the price of 1 transaction in Table I.